A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
Article in Proceedings of the National Academy of Sciences of the United States of America (January 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Licochalcone A Exerts Anti-Cancer Activity by Inhibiting STAT3 in SKOV3 Human Ovarian Cancer Cells
Article in Biomedicines (April 2023)
Biomarkers of everolimus efficacy in breast cancer therapy
Article in Journal of Oncology Pharmacy Practice (January 2022)